Search for Clinical Trial Results
Richter Syndrome - 20 Studies Found
Status | Study |
Completed |
Study Name: VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders Condition:
Date: 2006-03-15 Interventions: Drug: laromustine |
Completed |
Study Name: Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL Condition: Leukemia Date: 2007-03-23 Interventions:
|
Active, not recruiting |
Study Name: ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (Btk) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia Condition:
|
Recruiting |
Study Name: Study of Pembrolizumab in Combination With Ublituximab and TGR-1202 in Patients With Relapsed-refractory CLL or Richter's Transformation Condition: Chronic Lymphocytic Leukemia Date: 2015-08-24 Interventions:
|
Completed |
Study Name: Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT) Condition: Chronic Lymphocytic Leukemia Date: 2006-03-29 Interventions:
|
Withdrawn |
Study Name: Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation Condition:
|
Recruiting |
Study Name: Registry of the German CLL Study Group Condition:
|
Recruiting |
Study Name: Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL Condition:
|
Completed |
Study Name: Efficacy and Safety Study of PCI-32765 Combine With Ofatumumab in CLL Condition:
|
Active, not recruiting |
Study Name: ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies Condition:
Interventions: |